FDA Adverse Event
Injury
Summary report: N
AFX
MDR report key: 6142270
·
Received December 2, 2016
Report
- Report Number
- 2031527-2016-00560
- Event Type
- Injury
- Date Received
- December 2, 2016
- Date of Event
- November 3, 2016
- Report Date
- November 3, 2016
- Manufacturer
- ENDOLOGIX INC.
- Product Code
- MIH
- PMA / PMN Number
- P040002
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE DEVICES INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION, THEY REMAIN IMPLANTED IN THE PATIENT. IF ADDITIONAL INFORMATION PERTINENT TO THE INCIDENT IS OBTAINED, A FOLLOW-UP REPORT WILL BE SUBMITTED. DEVICES REMAIN IMPLANTED IN THE PATIENT.
Description of Event or Problem · 1
PATIENT INITIALLY IMPLANTED WITH A BIFURCATED STENT AND A SUPRARENAL AORTIC EXTENSION ON (B)(6) 2016. ON (B)(6) 2016 THE PATIENT UNDERWENT AN ANGIOGRAM WHERE A TYPE 2 ENDOLEAK WAS IDENTIFIED. THE PHYSICIAN ELECTED TO IMPLANT AN ADDITIONAL SUPRARENAL AORTIC EXTENSION AND A NON-ENDOLOGIX DEVICE TO RESOLVE THE ENDOLEAK. FINAL ANGIOGRAM SHOWED A SLIGHT TYPE 2 ENDOLEAK REMAINING. THE PATIENT WAS STABLE POST PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 792792 | AFX | BIFURCATED | MIH | ENDOLOGIX INC. | BA28-90/I16-30 | 1053243-016 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Required Intervention | SUPRARENAL AORTA UNI-ILIAC- 1204001-026 |